Clinical Trial

To Evaluate the Efficacy and Safety of the Transfemoral Mitral Valve Repair System in the Treatment of Patients With Moderately Severe and Severe Functional Mitral Regurgitation(FMR) Who Remained Clinically Symptomatic After Guideline-directed Medical Treatment

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 19, 2022 (before its estimated December 30, 2023 completion). Its status may not reflect the trial's current state.
Summary
To confirm the effectiveness and safety of the transcatheter mitral valve repair system for the treatment of chronic moderate to severe (3+) or severe (4+) functional mitral regurgitation (FMR) who remained clinically symptomatic after guideline-directed medical treatment.
Trial Details
NCT Number NCT05508438
Lead Sponsor Pan Xiangbin
Conditions Mitral Valve Insufficiency
Enrollment 140 participants
Start Date 2022-08-30
Primary Completion 2023-12-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2022-08-19